More drug companies cut list prices for insulin this week. NPR’s Scott Simon talks with Kaiser Health News reporter Bram Sable-Smith about what that means for patients.
NPR transcripts are created by an NPR contractor on an urgent deadline date. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authorized record of NPR programming is the audio log.